financetom
Business
financetom
/
Business
/
Chimera Investment Shares Fall After Q3 Net Interest Income Misses Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chimera Investment Shares Fall After Q3 Net Interest Income Misses Estimates
Nov 6, 2025 8:03 AM

10:27 AM EST, 11/06/2025 (MT Newswires) -- Chimera Investment ( CIM/PA ) shares were down more than 5% in recent Thursday trading after the company posted Q3 net interest income that missed analyst expectations.

The company reported Q3 adjusted earnings Thursday of $0.37 per diluted share, up from $0.36 a year earlier.

Net interest income for the quarter ended Sept. 30 was $65 million, compared with $66.5 million a year earlier.

Two analysts polled by FactSet expected $84.8 million.

Price: 12.37, Change: -0.61, Percent Change: -4.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Premier Signs $200 Million Accelerated Share Repurchase Deal With JPMorgan Chase
Premier Signs $200 Million Accelerated Share Repurchase Deal With JPMorgan Chase
Feb 18, 2025
09:02 AM EST, 02/18/2025 (MT Newswires) -- Premier (PINC) said Tuesday it signed accelerated share repurchase deals with JPMorgan Chase's ( JPM ) JPMorgan Chase Bank to buy back a total of $200 million of the company's class A common shares. Under the terms, Premier will pay $200 million to JPMorgan ( JPM ) and will receive initial deliveries of...
Nike, Skims Form New Brand Targeting Women's Fitness Apparel Industry
Nike, Skims Form New Brand Targeting Women's Fitness Apparel Industry
Feb 18, 2025
09:04 AM EST, 02/18/2025 (MT Newswires) -- Nike ( NKE ) said Tuesday it is partnering with Kim Kardashian-backed clothing brand Skims to form a new brand, NikeSKIMS. The new brand will focus on women's apparel, footwear, and accessories for the global fitness and activewear industry. NikeSKIMS will debut its initial collection in select U.S. retail stores and on its...
Biogen, Stoke Partner on Dravet Syndrome Investigational Drug Zorevunersen
Biogen, Stoke Partner on Dravet Syndrome Investigational Drug Zorevunersen
Feb 18, 2025
09:05 AM EST, 02/18/2025 (MT Newswires) -- Biogen (BIIB) and Stoke Therapeutics ( STOK ) said Tuesday they have partnered to develop and commercialize zorevunersen, Stoke's investigational treatment for Dravet syndrome, a rare genetic epilepsy. Stoke will receive $165 million upfront and may earn up to $385 million in milestone payments, along with royalties on sales in Biogen's territories, according...
Chartwell Declares February Distribution and Provides Occupancy Update
Chartwell Declares February Distribution and Provides Occupancy Update
Feb 18, 2025
09:06 AM EST, 02/18/2025 (MT Newswires) -- Chartwell Retirement Residences (CSH-UN.TO) on Tuesday declared a monthly cash distribution of $0.051 per trust unit, payable on March 17 to unitholders of record on Feb. 28. This latest distribution is unchanged from the prior month. The company said it has seen very robust winter sales, resulting in higher January occupancy and a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved